Home
/ Moderna
/ Competitors

Moderna Competitors and Similar CompaniesClear all

Moderna's competitors and similar companies include Regulus Therapeutics and Celyad.

	Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.	Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.	Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Founding Date	Founding Date 2010	Founding Date 2007	Founding Date 2007
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech healthtech pharma
Locations	Locations Cambridge, US HQ Melbourne, AU Paris, FR München, DE Tokyo, JP Seoul, KR Warszawa, PL see more	Locations San Diego, US HQ	Locations Mont-Saint-Guibert, BE HQ New York, US
Employees	Employees 5,60044% increase	Employees 2462% decrease	Employees 17
Valuation ($)	Valuation ($) 21.2 b	Valuation ($) 105.4 m	Valuation ($) 11.8 m
Financial
Revenue (est.)	Revenue (est.) $3.2b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) €102k (FY, 2023)
Cost of goods	Cost of goods $1.5b (FY, 2024)	Cost of goods N/A	Cost of goods €69k (FY, 2023)
Gross profit	Gross profit $1.8b (FY, 2024)	Gross profit N/A	Gross profit €1.4m (FY, 2023)
Net income	Net income ($3.6b) (FY, 2024)	Net income ($46.4m) (FY, 2024)	Net income (€8.4m) (FY, 2023)
Operating ⚠
Patents Issued	Patents Issued 270 (FY, 2020)	Patents Issued 300 (FY, 2016)	Patents Issued N/A
Funding
Total funding raised	Total funding raised $ 1.8b	Total funding raised $ 10m	Total funding raised N/A